To assess the postoperative analgesic efficacy of dexamethasone when added to ropivacaine in transversus abdominis plane block in lower abdominal surgeries.

Assessment of the postoperative analgesic efficacy of dexamethasone as an adjuvant to ropivacaine in transversus abdominis plane block in lower abdominal surgeries

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019601

Enrollment

Registered

2019-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexamethasone as an adjuvant to ropivacaine in transversus abdominis plane block: To compare the duration of postoperative analgesic effect,quality of postoperative analgesia(VNRS) and

Eligibility

Inclusion criteria

Inclusion criteria: 1) American Society Of Anesthesiologists(ASA) grade I and II. 2) Patients of either sex with age between 18 and 65 years. 3) Patients undergoing lower abdominal surgeries under general anaesthesia

Exclusion criteria

Exclusion criteria: 1) Patients with any contraindication to regional anaesthesia like refusal for TAP block and inability to give consent and with local skin infection. 2) BMI >30 kg per metre sq. 3) Patients with history of anaphylaxis to local anaesthetics. 4) Patient with history of any renal,hepatic,pulmonary,cardiac,hematological,endocrine and neuromuscular disorders. 5) Patients with history of chronic drug, analgesic or alcohol abuse. 6) Patients with history of any psychological disorder. 7) Consent refusal

Design outcomes

Primary

Measure	Time frame
1) To compare the duration of postoperative analgesic effect between 0.25% ropivacaine alone and 0.25% ropivacaine with 8mg dexamethasone in ultrasound guided transversus abdominis plane block. 2) To compare the quality of postoperative analgesia (VNRS) and total postoperative analgesic consumption in 24 hours between 0.25% ropivacaine alone and 0.25% ropivacaine with 8 mg dexamthasone in ultrasound guided transversus abdominis plane block.Timepoint: 1) Intra operative 2) Immediate post operative 3) 24 hours after the operation	—

Measure

Time frame

1) To compare the duration of postoperative analgesic effect between 0.25% ropivacaine alone and 0.25% ropivacaine with 8mg dexamethasone in ultrasound guided transversus abdominis plane block. 2) To compare the quality of postoperative analgesia (VNRS) and total postoperative analgesic consumption in 24 hours between 0.25% ropivacaine alone and 0.25% ropivacaine with 8 mg dexamthasone in ultrasound guided transversus abdominis plane block.Timepoint: 1) Intra operative 2) Immediate post operative 3) 24 hours after the operation

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactHimani Garg

G.G.S. medical college and hospital faridkot

doc_krishan31@yahoo.co.in9988316306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026